Please login to the form below
Lupin appoints Thierry Volle president for EMEA
He moves to the company from Vifor
Mumbai-based pharma company Lupin has appointed Thierry Volle to lead its Europe, Middle-East and Africa operations as president.
Volle will be responsible for the company's growth and development in Europe, Russia and CIS, as well as the Middle-East and African markets, and he will be based at Lupin's European headquarters in Zug, Switzerland.
He joins the firm from Vifor Pharma, where he was the head of EU and International business operations, and prior to that he served at Wyeth.
Vinita Gupta, Lupin's chief executive officer, said: "We are delighted to have Thierry join the Lupin family. His rich knowledge and experience in developing and growing businesses, specifically specialty pharmaceuticals in EMEA, will help us with our strategic expansion plans for these markets."
Featured jobs
-
Associate Scientific Director
-
Salary TBC
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Sudler London - Senior Medical Writer
-
Competitive
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Account Director or Senior Account Director
-
Salary TBC
-
Sudler London - Account Director
-
Competitive
-
Systematic Review Lead- London
-
Negotiable
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- Key success factor (KSF)
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- Gilead targets hep B in half a billion dollar deal with Precision BioSciences
- Lucid limbers up for second annual sports day
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Hanover Health launches award, Firstlight spins off healthcare arm and more
- J&J files ‘breakthrough’ bladder cancer drug in US
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
